BB Biotech AG
BBAGF News Today: Stay Updated with the Latest BB Biotech AG News in Real Time
Find BBAGF news now at Meyka AI. Stay informed with the latest BB Biotech AG stocks updates, including price news, market analysis, and expert insights.
CING Maintained at Buy by Roth Capital, May 2026
Roth Capital maintains Buy rating on Cingulate (CING) but cuts price target to $10 from $14, citing clinical trial progress.
Valerio Therapeutics Surges 13% on Strong Biotech Momentum
ALVIO.PA stock jumps 13% on EURONEXT. Clinical-stage biotech Valerio Therapeutics gains as oncology pipeline advances.
PHASQ Stock Collapses 99% as PhaseBio Bankruptcy Restructuring Continues
PHASQ stock plummets 99% to $0.000001 amid ongoing Chapter 11 bankruptcy. PhaseBio’s cardiovascular pipeline faces uncertain future.
MindMaze Therapeutics Holding S.A. (MMTX.SW) Surges 6.87% in Pre-Market Trading
MMTX.SW stock jumps 6.87% to CHF0.42 in pre-market session. MindMaze Therapeutics gains momentum on SIX exchange.
ABIVAX SA Stock Climbs 1.57% as Earnings Loom on May 25
ABVX.PA stock rises 1.57% to €97.10 ahead of May 25 earnings announcement. Biotech firm develops ABX464 for inflammatory and infectious diseases.
RLAY: Raymond James Maintains Strong Buy, Raises Price Target to $26
Raymond James maintains Strong Buy rating on RLAY, raises price target to $26 from $23 on May 19, 2026.
Open Orphan Plc (ORPH.IR) Holds Steady at €0.14 on Volume Surge
ORPH.IR stock trades flat at €0.14 with volume spike to 15,112 shares. Biotech firm shows strong fundamentals with 7.7x P/E ratio on EURONEXT.
ChitogenX Inc. Stock Hits 9-Year Low at C$0.005 on Biotech Setbacks
CHGX.CN stock trades at C$0.005, down 99.5% from peak. Biotech firm faces cash burn and negative metrics.
Regeneus Ltd Surges 33% on Pre-Market Volume Spike
RGS.AX stock jumps 33% in pre-market trading with volume 6.9x average. Biotech firm trades at A$0.012 on ASX.